Država: Nova Zelandija
Jezik: angleščina
Source: Medsafe (Medicines Safety Authority)
Clobetasol propionate 0.5 mg/g
Boucher & Muir (New Zealand) Limited t/a BNM Group
Clobetasol propionate 0.5 mg/g
0.5 mg/g
Topical cream
Active: Clobetasol propionate 0.5 mg/g Excipient: Cetostearyl alcohol Chlorocresol Citric acid monohydrate Glycerol Glyceryl 1-monostearate Propylene glycol Purified water Sodium citrate White beeswax
Prescription
Symbiotec Pharmalab Limited
Treatment of resistant dermatoses such as psoriasis (excluding widespread plaque psoriasis), recalcitrant eczemas, lichen planus and discoid lupus eyrthematosus and other skin conditions which do not respond satisfactorily to less active steroids.
Package - Contents - Shelf Life: Tube, aluminium, laquered, collapsible aluminium tube with polypropylene cap, secondary carton - 30 g - 24 months from date of manufacture stored at or below 25°C 3 months opened stored at or below 30°C. (in use) - Tube, aluminium, laquered, collapsible aluminium tube with polypropylene cap, secondary carton - 100 g - 24 months from date of manufacture stored at or below 25°C 3 months opened stored at or below 30°C. (in use)
2014-05-05
1 CLOBETASOL CREAM CLOBETASOL OINTMENT 15092016 New Zealand Consumer Medicine Information CLOBETASOL CREAM CLOBETASOL OINTMENT _ _ _CLOBETASOL PROPIONATE _0.05% W/W _ _ CREAM / OINTMENT WHAT IS IN THIS LEAFLET Please read this leaflet carefully before you start using Clobetasol Cream or Ointment. This leaflet answers some common questions about Clobetasol Cream and Ointment. It does not contain all the available information. The most up-to-date Consumer Medicine Information can be downloaded from www.medsafe.govt.nz. Reading this leaflet does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using Clobetasol Cream or Ointment against the benefits this medicine is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may want to read it again. WHAT CLOBETASOL CREAM AND OINTMENT ARE USED FOR Clobetasol Cream and Ointment contain the active ingredient clobetasol propionate. Clobestasol belongs to a group of medicines known as topical steroids. “Topical” means that they are applied onto the skin. Topical steroids are used to help reduce inflammation in the affected area which helps to reduce redness and itchiness caused by the skin disease. Clobetasol Cream and Ointment are used to treat various inflamed skin conditions which do not respond to less active steroids, including: psoriasis (a stubborn skin disorder with raised, rough, reddened areas covered with dry, fine silvery scales) severe forms of eczema (an often itchy skin condition with redness, swelling, oozing of fluid, crusting which may lead to scaling) lichen planus (chronic itchy skin of unknown origin) discoid lupus erythematosus (recurring scaly rash) 2 CLOBETASOL CREAM CLOBETASOL OINTMENT 15092016 Clobetasol Cream is used to treat skin conditions on moist or weeping surfaces whereas Clobetasol Ointment is more suitable for dry, scaly skin. Your doctor Preberite celoten dokument
1 CLOBETASOL CREAM CLOBETASOL OINTMENT 26082016 NEW ZEALAND DATA SHEET CLOBETASOL CREAM CLOBETASOL OINTMENT clobetasol propionate CREAM AND OINTMENT 0.05% w/w PRESENTATIONS Clobetasol Cream and Ointment each contain 0.05% w/w clobetasol propionate (1 g of cream/ointment contains 0.5 mg of clobetasol 17-propionate). The water-miscible cream and the paraffin-based ointment are both white in appearance. INDICATIONS Treatment of resistant dermatoses such as psoriasis (excluding widespread plaque psoriasis), recalcitrant eczemas, lichen planus and discoid lupus erythematosus and other skin conditions which do not respond satisfactorily to less active steroids. DOSAGE AND ADMINISTRATION Creams are especially appropriate for moist or weeping surfaces. Ointments are especially appropriate for dry, lichenified or scaly lesions. Adults, elderly and children over 1 year _ _ Apply thinly and gently rub in using only enough to cover the entire affected area once or twice daily until improvement occurs (in the more responsive conditions this may be within a few days), then reduce the frequency of application or change the treatment to a less potent preparation. Allow adequate time for absorption after each application before applying an emollient. Repeated short courses of Clobetasol Cream or Ointment may be used to control exacerbations. In very resistant lesions, especially where there is hyperkeratosis, the effect of Clobetasol Cream or Ointment can be enhanced, if necessary, by occluding the treatment area with polythene film. Overnight occlusion only is usually adequate to bring about a satisfactory response. Thereafter improvement can usually be maintained by application without occlusion. 2 CLOBETASOL CREAM CLOBETASOL OINTMENT 26082016 If the condition worsens or does not improve within 2-4 weeks, treatment and diagnosis should be re-evaluated. Treatment should not be continued for more than 4 weeks. If continuous treatment is necessary, a less potent preparation should be used. The maximum weekly dose should not exceed Preberite celoten dokument